Investing in stock markets is an excellent strategy to create wealth. You do not need a substantial amount to start your investment trip. Small but regular investments would help investors to build up wealth in the long term. In the meantime, the following two shares offer healthy growth prospects and act under $ 20, making them ideal purchases for long -term investors.
Savaria
Savaria (TSX: SIS) offers accessibility solutions for people with disabilities with its production facilities spread all over the world. The company also sells its products worldwide through its dealer networks and direct sales offices in North America, Europe, Australia and China. The growth and increasing income levels of the aging population can stimulate the demand for accessibility solutions, creating a long -term growth potential for the company.
Moreover, Savaria focuses on the development of innovative products. It has also made structural improvements that can improve its production capacity, increase operational efficiency and streamline purchasing, generating substantial cost savings. The company also acquired Western Elift, which generated $ 7.5 million in income last year. The acquisition would strengthen the position of Savaria in the luxury residential lift market.
On the back of these initiatives, the management of the company predicts its 2025 turnover to be around $ 925 million, which represents 6.6% of the growth on an annual basis. Also, the management that its adapted EBITDA (profit before interest, tax, depreciation and amortization) will expect margin between 17% and 20%, compared to 18.6% in 2024. In addition, Savaria currently offers a monthly dividend payment of $ 0.045/share, with a forward dividend render. It is also traded against a reasonable NTM-PRIJS-Tot-Sales plural of 1.5, making it an excellent purchase.
Good health technologies
The second shares under $ 20 that I am optimistic about is, is Good health technologies (TSX: Well), who offers products and services to help healthcare professionals deliver positive patient results. In the meantime, the growing popularity of virtual healthcare services and the digitization of clinical procedures have created a long -term growth potential for the company. It had 1.6 million patient visits during the first quarter, which represents an increase of 23% compared to the previous year.
Furthermore, Well Health invests in artificial intelligence to develop innovative products and functions that can strengthen its position in virtual health care and clinical documentation services. Together with organic growth, the company continues with its inorganic extensions. Earlier this month it acquired two clinics, which can generate around $ 12 million in annual turnover and around $ 3 million in adapted EBITDA. The company’s acquisition pipeline consists of 124 clinics, which can add $ 370 million to annual turnover and $ 50 million to adapted EBITDA.
In the midst of these healthy growth prospects, the management of Well Health projects its 2025 turnover between $ 1.35 billion and $ 1.40 billion, excluding the impact of the deferred income adjustments of Circle Medical. The center of the income guidance of management represents an increase of 49.5%on an annual basis. In the meantime, management also expects the adapted EBITDA to be between $ 140 million and $ 160 million, whereby the center of supervision represents an increase of more than 18% compared to 2024.
In addition, Well Health announced a new share -repeated plan in May, where it will purchase around 6.3 million shares in the coming 12 months, which represents 2.5% of the outstanding shares. Together with these factors, the attractive NTM-PRIJS profit makes several of 10.6 it an excellent long-term purchase.
#good #shares #buy